<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab1">
 <label>Table 1</label>
 <caption>
  <p>Characteristics of SARS-CoV and SARS-CoV-2</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Characteristics</th>
    <th>SARS-CoV</th>
    <th>SARS-CoV-2</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Species</td>
    <td>β Coronavirus, beta-CoV, lineage B</td>
    <td>β Coronavirus, beta-CoV, lineage B</td>
   </tr>
   <tr>
    <td>Origin</td>
    <td>Bat</td>
    <td>Bat</td>
   </tr>
   <tr>
    <td>Intermediate hosts</td>
    <td>Not known</td>
    <td>
     <italic>Manis pentadactyla</italic>
     <sup>
      <xref ref-type="bibr" rid="CR68">68</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td>Genetic material</td>
    <td>Positive-stranded RNA</td>
    <td>Positive-stranded RNA</td>
   </tr>
   <tr>
    <td>Receptor</td>
    <td>Angiotensin-converting enzyme 2 (ACE2)</td>
    <td>Angiotensin-converting enzyme 2 (ACE2)</td>
   </tr>
   <tr>
    <td>Route of transmission</td>
    <td>Respiratory droplets, close contact, fecal-oral route (?)</td>
    <td>Respiratory droplets, close contact, fecal-oral route (?)</td>
   </tr>
   <tr>
    <td>Incubation period</td>
    <td>5 (2–10) days (
     <ext-link ext-link-type="uri" xlink:href="https://www.who.int/csr/sars/postoutbreak/en/" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.who.int/csr/sars/postoutbreak/en/</ext-link>)
    </td>
    <td>5.2 (1.8–12.4) days
     <sup>
      <xref ref-type="bibr" rid="CR69">69</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td>Clinical symptoms</td>
    <td>Fever (99%), Documented elevated temperature (85%), Nonproductive cough (69%), Myalgia (49%), Dyspnea (42%)
     <sup>
      <xref ref-type="bibr" rid="CR70">70</xref>
     </sup>
    </td>
    <td>Fever (83%), Cough (82%), Shortness of breath (31%), Muscle ache (11%), Confusion (9%), Headache (8%), Sore throat (5%), Rhinorrhoea (4%), Chest pain (2%), Diarrhea (2%), Nausea and vomiting (1%)
     <sup>
      <xref ref-type="bibr" rid="CR71">71</xref>
     </sup>
    </td>
   </tr>
   <tr>
    <td>Fatality rate</td>
    <td>9.6%</td>
    <td>~3.1%
     <sup>a</sup>
    </td>
   </tr>
   <tr>
    <td>Epidemic area</td>
    <td>Asia, Europe, North, and South America</td>
    <td>Globally</td>
   </tr>
   <tr>
    <td>Epidemic time</td>
    <td>~8 months</td>
    <td>Unknown</td>
   </tr>
   <tr>
    <td>High-risk for severe illness</td>
    <td>Young and middle-aged</td>
    <td>Elderly or frail with underlying disease</td>
   </tr>
   <tr>
    <td>Possibility of recurrence</td>
    <td>Very unlikely</td>
    <td>Very likely</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>
   <sup>a</sup>Calculated based on the total number of the confirmed cases and deaths as of Sep 19, 2020
  </p>
 </table-wrap-foot>
</table-wrap>
